# LivaNova clinical trials: 40 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 40 trials with LivaNova as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by LivaNova: 40 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/livanova

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 40
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 40, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 4, 2023 | NCT05975931 | IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes. | LivaNova | Observational | Terminated | Epilepsy | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05975931) |
| July 6, 2021 | NCT04950894 | Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation | LivaNova | Not applicable | Completed | Obstructive Sleep Apnea, OSA, Apnea, Apnea, Obstructive, Apnea, Obstructive Sleep, Apnea+Hypopnea, Hypopnea, Sleep | 107 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04950894) |
| March 3, 2021 | NCT04779814 | Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associated With VNS Therapy in UK. | LivaNova | Observational | Terminated | Epilepsy | 97 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04779814) |
| February 15, 2021 | NCT04753385 | The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for... | LivaNova | Observational | Terminated | Treatment Resistant Depression | 138 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04753385) |
| February 25, 2020 | NCT04282681 | XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU) | LivaNova | Observational | Withdrawn | Epilepsy, Tonic-Clonic | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04282681) |
| March 25, 2019 | NCT03887715 | A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as... | LivaNova | Not applicable | Recruiting | Treatment Resistant Depression | 6,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03887715) |
| May 18, 2018 | NCT03529045 | Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. | LivaNova | Observational | Completed | Epilepsy, Seizures, Drug Resistant Epilepsy | 827 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03529045) |
| February 27, 2018 | NCT03446664 | Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study | LivaNova | Not applicable | Completed | Epilepsies, Partial, Epilepsy, Tonic-Clonic | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03446664) |
| February 7, 2018 | NCT03425422 | ANTHEM-HFrEF Pivotal Study | LivaNova | Not applicable | Terminated | Heart Failure, Heart Failure, Congestive, Heart Failure, Systolic | 533 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03425422) |
| October 25, 2017 | NCT03320304 | A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression. | LivaNova | Observational | Recruiting | Treatment Resistant Depression | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03320304) |
| October 3, 2017 | NCT03300037 | HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor | LivaNova | Observational | Completed | Sleep Apnea, Obstructive | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03300037) |
| April 25, 2017 | NCT03127202 | Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve Stimulation | LivaNova | Not applicable | Completed | Heart Failure | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03127202) |
| January 9, 2017 | NCT03014180 | Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm (LEVEA) | LivaNova | Not applicable | Completed | Heart Failure | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03014180) |
| August 17, 2016 | NCT02870647 | Sleep Apnea, Arrhythmias and Cardiac Reverse Remodeling in Heart Failure Patients | LivaNova | Phase 4 | Withdrawn | Sleep Breathing Disorders in the Responders to Cardiac Resynchronisation Therapy (CRT) | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02870647) |
| June 3, 2016 | NCT02789748 | PErsonalized and Adaptive Kinesthetic stImulation Therapy, Based on Cardio-respiratory Holter moNitoring, for Sleep Apnea syndrOmes | LivaNova | Not applicable | Completed | Obstructive Sleep Apnea Syndrome | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02789748) |
| October 26, 2015 | NCT02586480 | Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode | LivaNova | Observational | Completed | Sinus Node Dysfunction, Atrioventricular Block | 848 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02586480) |
| October 16, 2015 | NCT02577445 | The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice | LivaNova | Observational | Terminated | Sleep Apnea, Central Sleep Disordered Breathing | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02577445) |
| January 30, 2015 | NCT02351726 | Mitroflow DL Post Approval Study- North America | LivaNova | Not applicable | Terminated | Aortic Stenosis, Aortic Regurgitation, Aortic Valve Insufficiency, Heart Valve Diseases, Cardiovascular Abnormalities... | 186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02351726) |
| October 1, 2014 | NCT02253134 | Monitoring of Syncopes and/or Sustained Palpitations of Suspected Arrhythmic Origin With External Loop-Recorder (SpiderFLASH) | LivaNova | Observational | Completed | Syncope, Palpitations | 395 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02253134) |
| September 26, 2014 | NCT02250547 | Optimization With SonR Method in the ClinicAl pRactice | LivaNova | Observational | Completed | CRT Patients | 278 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02250547) |
| June 19, 2014 | NCT02167789 | Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device | LivaNova | Phase 3 | Completed | Heart Failure | 520 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02167789) |
| April 14, 2014 | NCT02113033 | VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients | LivaNova | Phase 2 | Completed | Heart Failure With Reduced Ejection Fraction | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02113033) |
| November 21, 2012 | NCT01731210 | Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation (LENEA) | LivaNova | Phase 2/3 | Terminated | LV Lead, LV Therapy, LV Treatment, LV Microcable | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01731210) |
| February 23, 2012 | NCT01537718 | Evaluation of the Performances of the Sleep Disordered Breathing Monitoring Function in Pacemaker | LivaNova | Phase 3 | Completed | Bradycardia | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01537718) |
| April 25, 2011 | NCT01341522 | Clinical Evaluation of the Sorin Group's REPLY MR-conditional Pacing System | LivaNova | Phase 3 | Withdrawn | Dual-chamber Pacemaker Placement | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01341522) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Phase 3 | 5 |
| Phase 4 | 10 |
| Not applicable | 8 |
| Observational | 15 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 27 |
| Terminated | 8 |
| Withdrawn | 3 |
| Recruiting | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Heart Failure | 9 |
| Depressive Disorder, Treatment-Resistant | 3 |
| Sleep Apnea Syndromes | 3 |
| Sleep Apnea, Obstructive | 3 |
| Epilepsy | 3 |
| Drug Resistant Epilepsy | 3 |
| Sick Sinus Syndrome | 3 |
| Depression | 2 |
| Atrioventricular Block | 2 |
| Epilepsy, Tonic-Clonic | 2 |
| Bradycardia | 2 |
| Cardiomyopathies | 1 |
| Neuronal Ceroid-Lipofuscinoses | 1 |
| Seizures | 1 |
| Patient Acceptance of Health Care | 1 |
| Sleep Apnea, Central | 1 |
| Epilepsies, Partial | 1 |
| Aortic Valve Stenosis | 1 |
| Aortic Valve Insufficiency | 1 |
| Heart Valve Diseases | 1 |
| Cardiovascular Abnormalities | 1 |
| Cardiovascular Diseases | 1 |
| Congenital Abnormalities | 1 |
| Heart Diseases | 1 |
| Pathological Conditions, Anatomical | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Cement suppliers in the United States](https://specstream.ai/data/businesses/cement-suppliers/united-states)
- [Industrial equipment manufacturers in the United States](https://specstream.ai/data/businesses/industrial-equipment-manufacturers/united-states)
- [Sandblasting companies in the United States](https://specstream.ai/data/businesses/sandblasting-companies/united-states)
- [Bar and grill restaurants in the United States](https://specstream.ai/data/businesses/bar-and-grill-restaurants/united-states)
- [German restaurants in the United States](https://specstream.ai/data/businesses/german-restaurants/united-states)
- [Powder coating companies in the United States](https://specstream.ai/data/businesses/powder-coating-companies/united-states)
